Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000269069 is a pseudogene annotated as "Protein Associated With Topoisomerase II Homolog 1 (Yeast) (PATL1) Pseudogene." It does not encode a functional protein and is not involved in any therapeutic or diagnostic applications. Pseudogenes generally arise from duplication or retrotransposition events and lack biological activity unless re-purposed for regulatory functions, which is not described for this entry. This entry is not a drug target, receptor, enzyme, transporter, or any known functionally important molecule for therapy or biomarker discovery. There is nothing to suggest this pseudogene is misspelled, but it is "incorrect" for drug/target receptor lists because it is not a protein-coding or functional molecular target. If you need information on functional topoisomerase II protein targets (such as topoisomerase II alpha or beta), those are distinct genes, with well-established therapeutic roles. ENSG00000269069 is a properly annotated pseudogene ("Protein Associated With Topoisomerase II Homolog 1 pseudogene"), not a molecular target. All pharmacologically relevant information is null for this entry.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Associated With Topoisomerase II Homolog 1 (Yeast) Pseudogene (ENSG00000269069).